Cost-Effectiveness

November 2019

Low Back Pain

  • A 2018 cross-sectional study of insurance plans that together represented over half the U.S. population examined coverage policies for 5 nonpharmacologic approaches commonly used to treat acute or chronic low back pain among commercial and Medicare Advantage insurance plans, plus an additional 6 treatments among Medicaid plans.

    The rest of this research summary including the annotated bibliography with links to every article is only available to Clinical Compass Evidence Center Subscribers

    If you are you a Clinical Compass Evidence Center Subscriber, please CLICK HERE TO LOGIN
    If you are not yet a Clinical Compass Evidence Center Subscriber, CLICK HERE to learn how to access all of our research summaries for a 100% tax deductible donation of as little as $5 per month.

     

A literature synthesis of Cost Effectiveness of various conditions — an academically rigorous analysis of all the available scientific literature using internationally accepted tools to rate each article according to specific criteria indicating only what we can conclude with supportable, scientific evidence.